Investment
Features
FeesSafety
Academy
More
Pluang+

Compare American States Water Company (AWR) vs GeneDx Holdings Corp (WGS) Price & Performance

American States Water CompanyTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

American States Water Company vs GeneDx Holdings Corp — how do they compare? American States Water Company trades at $84.66 (market cap $3.33B), while GeneDx Holdings Corp trades at $62.13 (market cap $1.85B). The key difference: American States Water Company is the larger of the two by market cap, and American States Water Company pays a 2.37% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.

AWRWGS
Market Cap
$3.33B$1.85B
Sector
UtilitiesTechnology
52-Week High
$85.05$167.51
52-Week Low
$70.10$34.51
Enterprise Value
$4.24B$1.85B
Dividend Yield
2.37%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

American States Water Company

American States Water (AWR) trades at $85.05, up 0.64% today, with a bullish technical signal from moving averages and strong profitability metrics including a 19.66% net income margin. Recent news highlights its inclusion in TIME's America's Best Companies 2026 list and a completed $200 million ATM equity offering. The stock shows consistent dividend performance with a 71-year growth streak, though recent quarters saw mixed earnings results versus expectations.

Outlook remains stable with revenue growth to $679 million in 2026 and solid cash flow, but risks include regulatory pressures and interest rate sensitivity. Analysts are cautious with only 20% buy ratings. The stock offers defensive appeal but faces execution risks in a high-valuation environment.

GeneDx Holdings Corp

GeneDx Holdings (WGS) trades at $63.85, down 2.73% amid multiple securities class action lawsuits alleging misleading acquisition performance disclosures. The stock shows bearish technical signals with support at $60 and resistance at $65. Fundamentally, the company reported negative net income of -$21.02M for 2025 despite revenue growth to $427.54M, with profitability metrics deteriorating significantly in 2026 projections.

Despite 91% analyst buy ratings and a $75.40 consensus target, substantial legal risks and negative earnings momentum create significant headwinds. The stock faces near-term pressure from litigation while long-term viability depends on reversing negative margin trends and resolving acquisition-related impairment issues that triggered the 49% stock decline cited in lawsuits.

Returns comparison

Trailing returns across standard periods

About American States Water Company

American States Water provides water and electric services to over one million people in the U.S. It also manages water and wastewater systems for various military bases under long-term privatization contracts.

Read more on AWR

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS